GAGNON ROBERT E. (Chief Financial Officer) sold 4.8% of their position (28K shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $127.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2026ACC: 0001140361-26-035912
Officer· Chief Financial Officer
Since Sep 2025
-28K
Net shares
Net seller
$127.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−28K
Price / share
$4.54
Trade value
$127.21K
% of position
4.8%
9/3/2026
584.38K→556.38K
Total
Net shares
−28K
Net value
-$127.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2026 | S · Sale | −28K | $4.54 | $127.21K | 4.8% | 584.38K | 556.38K |
| Total | −28K | -$127.21K | ||||||
Derivative Transactions0
No derivative transactions reported